In the present study, endothelin (ET) agonists and receptor selective antag
onists were used to characterize ET receptors mediating constriction in gui
nea pig mesenteric veins (250-300 mu m diameter) in vitro. The contribution
of ET-evoked vasodilator release to venous tone was also explored. Compute
r-assisted video microscopy was used to monitor vein diameter. Endothelin-1
(ET-1), endothelin-3 (ET-3), and sarafotoxin 6c (S6c) produced sustained c
oncentration-dependent contractions with a rank order agonist potency of ET
-1 = S6c > ET-3. Indomethacin (1 mu M) and Na-nitro-L-arginine (100 mu M) e
nhanced ET-1 and S6c responses. The ETA selective antagonists BQ-610 (100 n
M) and PD156707 (10 nM) shifted ET-1 concentration-response curves rightwar
d and decreased maximal ET-1 responses, without changing S6c responses. The
ETB selective antagonist BQ-788 (100 nM) shifted S6c responses rightward b
ut produced no change in ET-1 responses. Combined application of BQ-788 and
BQ-610 or BQ-788 and PD 156707 produced a rightward shift in ET-1 response
s that was greater than shifts produced by BQ-610 or PD 156707 alone. In co
nclusion, smooth muscle in guinea pig mesenteric veins expresses ETA and ET
B receptors coupled to contractile mechanisms. Activation of endothelial ET
B receptors results in release of vasodilators, primarily nitric oxide.